Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Odonate Therapeutics in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in Odonate Therapeutics. This rating has held steady since February 2022, when it changed from a Hold consensus rating.